Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 pilot study of pregabalin in postherpetic neuralgia
2011-005972-41Phase 4Terminated
- Sponsor
- Pfizer
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pregabalin in postherpetic neuralgia (PHN), sponsored by Pfizer. Primary endpoint: Change in daily pain diary mean pain score. Started May 2012; status: terminated.
02
Drugs
pregabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on 2011-005972-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005972-41.